Trusted Resource for Clinical Trials, Protocols & Progress
Wearable technology has revolutionized modern clinical trials, offering continuous, real-time patient data capture in natural environments. Unlike traditional site visits, wearable devices empower decentralized, patient-centric models that enhance data quality and reduce burden on subjects. From tracking ECGs to detecting sleep disorders, wearables are becoming pivotal in clinical study design and execution.
Click to read the full article.
Wearable technology is no longer a futuristic concept—it’s a present-day enabler of transformation in clinical trials. The convergence of biosensors, artificial intelligence, and miniaturized electronics has led to an explosion of wearable devices that are now central to decentralized clinical trials (DCTs). These devices are enabling real-time, patient-generated data collection in naturalistic settings, offering a richer understanding of patient health outside traditional clinical sites.
Click to read the full article.
Wearable devices have revolutionized clinical trials by enabling passive, continuous, and real-world data capture. However, unlike traditional lab instruments, wearables are consumer-facing technologies that must undergo rigorous scrutiny to meet regulatory standards like GCP, 21 CFR Part 11, and Annex 11. The validation of wearable-derived data is crucial to ensure:
Click to read the full article.
Remote data capture has revolutionized modern clinical trials, enabling real-time, continuous monitoring of patient vitals, activity, and therapeutic responses. Devices such as smartwatches, biosensor patches, ECG chest straps, and mobile-connected glucometers have replaced periodic, site-based assessments in many studies. While this offers flexibility, increased patient retention, and richer data, it also introduces new validation, data integrity, and GxP compliance challenges.
Click to read the full article.
Continuous monitoring using wearable devices has transformed the landscape of modern clinical trials, especially those adopting decentralized or hybrid models. These devices—ranging from smartwatches to biosensor patches—allow sponsors to collect real-time physiological data such as heart rate, respiratory rate, skin temperature, and sleep metrics with minimal subject intervention. This transition supports longitudinal data collection without requiring constant site visits, enabling more patient-centric trial designs.
Click to read the full article.
Traditional adverse event (AE) detection in clinical trials has heavily relied on site-reported symptoms, patient self-reporting, or scheduled assessments. However, this method often misses transient, asymptomatic, or nocturnal events. With the advent of wearable sensors and biosignal analytics, trials can now proactively monitor physiological parameters 24/7—allowing the detection of subtle and early indicators of AEs in near real-time.
Click to read the full article.
Wearable technologies are transforming how clinical trials are conducted, offering real-time data capture, continuous monitoring, and improved patient convenience. However, selecting the appropriate device is critical. A poorly chosen device can compromise data quality, affect patient adherence, and even jeopardize regulatory compliance. Clinical teams must align device capabilities with protocol endpoints, site capacity, and subject demographics.
Click to read the full article.
Wearable technologies—such as smartwatches, biosensors, and patches—are transforming clinical trials. However, implementing wearables in pediatric and geriatric populations presents unique challenges. These groups represent physiologically, cognitively, and ethically sensitive patient populations that require custom-designed devices, careful monitoring, and strong regulatory alignment.
Click to read the full article.
Wearable devices are revolutionizing clinical trials by enabling real-time, continuous data capture from participants. These include smartwatches, ECG patches, biosensors, and fitness trackers. However, capturing this data is only half the challenge—integrating it into Electronic Data Capture (EDC) systems in a GxP-compliant manner is the critical next step.
Click to read the full article.
Digital health tools—including wearable devices, mobile apps, and AI-driven sensors—are rapidly transforming clinical trials. These technologies offer real-time data capture, remote monitoring, and improved patient engagement. However, the use of such tools in regulated studies demands compliance with complex frameworks set forth by agencies like the FDA and EMA.
Click to read the full article.
